Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication (DREAM)

Pfizer

Status: Completed

Conditions: Deep Mycosis

Treatments: Drug: Fluconazole

Study type: Observational

Funder types: Industry

Identifiers

NCT01680458

A0561022

Details and patient eligibility

About

To collect the efficacy and safety information of fluconazole on infant subjects related to their appropriate use in daily practice.

Enrollment: 30 patients

Sex: All

Ages: Under 6 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or Female under age of seven patients who are prescribed fluconazole (Diflucan) for antifungal treatment or prophylaxis administration.

Exclusion criteria

• Subject of seven years or more who have been prescribed fluconazole.

Trial design

30 participants in 1 patient group

fluconazole

Description:

Infant Subjects who are treated with fluconazole

Treatment:

Drug: Fluconazole